Weifeng Feng,1 Heqi Liu2 

1Department of Cosmetic Surgery, Beijing Badachu Plastic Surgery, Fifth Medical Aesthetic Hospital, Beijing, 102600, People’s Republic of China; 2Department of Anesthesiology, Beijing Children’s Hospital, Capital Medical University, National Center for Children’s Health, Beijing, 100045, People’s Republic of China

Correspondence: Weifeng Feng, Department of Cosmetic Surgery, Beijing Badachu Plastic Surgery, Fifth Medical Aesthetic Hospital, Building C3-C4, Starlight Vision Park, No. 1 hongye East Road, Daxing District, Beijing, 102600, People’s Republic of China, Tel +86 18202494986, Email finn_ps@qq.com

Abstract: Botulinum toxin serotype A (BTX-A) is commonly used for treating facial dynamic wrinkles. The clinical safety of BTX-A has been proven, and it has few side effects; despite this, BTX-A has the potential to cause an allergic reaction. This case raises concerns about a possible interaction between botulinum toxin serotype A (CBTX-A) and β-lactam antibiotics, contributing to the limited literature on hypersensitivity reactions. Herein, we described the case of a 35-year-old woman who was injected with Chinese botulinum toxin serotype A (CBTX-A) to treat crow’s feet. The treatment was performed after the patient had taken cefprozil for an upper respiratory tract infection. Subsequently, the patient developed urticaria-like symptoms that completely resolved within 24 hours after administration of antihistamines. This case emphasises the need for careful medication history review before botulinum toxin administration, especially in patients receiving β-lactam antibiotics, as hypersensitivity reactions may occur.

Keywords: botulinum toxin, β-lactam, hypersensitivity